drugset / Trial / NCT00003078

Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix

NCT00003078 ↗

RandomizedTreatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy and chemotherapy may kill more tumor cells. It is not known whether receiving radiation therapy plus cisplatin is more effective than receiving radiation therapy plus fluorouracil in treating patients with cancer of the cervix. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy plus cisplatin or fluorouracil in treating patients with primary stage IIB, stage IIIB, or stage IVA cancer of the cervix.

Timeline

Start
1997-10
Primary completion
2005-11
Completion
—

Outcome

Missed primary endpoint

paper The study was closed prematurely when a planned interim futility analysis indicated that PVI FU/RT had a higher treatment failure rate PMID 16230678 ↗

paper In this study, PVI FU does not show improved outcome over weekly cisplatin. PMID 16230678 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 40 mg/m2 Intravenous
Subject fluorouracil Small molecule 225 mg/m2 Intravenous

Indications